Comparing Interventions for Indoor Air -Related Functional Symptoms (TOSI)

August 6, 2018 updated by: Finnish Institute of Occupational Health

Psychosocial Interventions for Indoor Air -Related Functional Symptoms - Randomized Controlled Trial (RCT)

The aim of the current study is to compare the effictiveness of three different psychosocial therapies for treating functional disorders caused by indoor air problems.

Study Overview

Detailed Description

Indoor air -related respiratory and other multiple organ symptoms are common in work environments in Finland. Symptoms effect on well-being and quality of life and may lead to impaired social and cognitive functioning and decreased work ability. All indoor air -related conditions are not explained by underlying physical factors and remain medically unexplained. Functional disorders are conditions where patients complain of multiple medically unexplained physical symptoms or physical problems don´t correlate with symptom severity. Indoor air -related symptoms and functional disorders are strongly associated to each other but there are no well-established diagnostic criteria for the condition . So far, there is no available treatment program to the indoor air -related symptoms to offer in primary or occupational health care services in Finland.

In randomized controlled trials, cognitive behavioral treatment has shown to be effective for patients suffering from functional disorders. In addition, a relaxation technique entitled as applied relaxation (Tuomisto & al, 1996) have shown to been shown to been effective to treat different kind of functional problems.

There are no published trials on treatment for individuals of indoor air related symptomatology. The present study is designed as a pragmatic trial to investigate the effect of three different treatment programs as compared to treatment as usual (TAU) for indoor air- related problems in order to improve the (1) work capacity and (2) well-being. A secondary aim of the study is to identify psychological factors affecting the patients' response to the treatment.

The patients are recruited from occupational health care services to establish and to evaluate the efficacy and usability of the treatment procedures. Participants will first undergo baseline assessment including medical examination of the respiratory symptoms. Then they are randomized to one of the study groups: TAU or one of the intervention groups. All study patients receive TAU at occupational health care services for their medical problems during the study. Patients randomized to the study groups receive also the intervention with TAU.

Study Type

Interventional

Enrollment (Actual)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Uusimaa
      • Helsinki, Uusimaa, Finland, 00250
        • Finnish Institute of Occupational Health (Finland)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 58 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Self-assessed work ability not more than 7 (on a scale 0-10, compared to lifetime best) (removed, see below)
  2. Employed minimum three (3) or more years
  3. Symptoms related to work environment indoor air (non-industrial workplaces)
  4. Respiratory symptoms related to indoor air
  5. And symptoms involve more than one other organ system
  6. Symptoms onset maximum three years before the study
  7. Symptoms are recurrent
  8. Symptoms appear more than one (1) environment or continue after repairs environmental exposure(s)
  9. No single widely acceptable test of organ system function can explain the symptoms (symptoms are medically unexplained)
  10. Minimum of one sick leave due to indoor air symptoms during the preceding half year
  11. Fluent Finnish (write/read/speak) (due the interventions)

Exclusion Criteria:

  1. six (6) months or more sick leave sick leaves due to indoor air symptoms during the preceding two years and currently unable to work
  2. Planned changes in the work (for example retirement, study free period, pregnancy etc.) during the study
  3. An acute, untreated medical disorder or illnesses:

    1. Somatic disease that explains the symptoms
    2. An acute, untreated mental disorder (depression, bipolar disorder, psychotic disorders, obsessive-compulsive disorder, eating disorders, personality disorders)
    3. Abuse of narcotics or alcohol or (non-prescribed) medicine
    4. Developmental disorders
  4. Psychotherapy (current or has ended preceding two years)
  5. No inform consent
  6. Other: Patient refusal; not actively participating working life (retired or unemployed)

Based on a steering group´s advice and agreement (10.10.2014), inclusion criteria (Self-assessed work ability not more than 7, on a scale 0-10, compared to lifetime best) was removed. Recruitment continues without this question as an inclusion criteria.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cognitive-Behavioral Therapy (CBT)

There will be ten (10) manualized session, fist 90 minutes and nine (9) 45-minute individual sessions conducted at weekly intervals, last two sessions 2 weeks intervals. One booster session will be conducted three months after the treatment. Sessions include psychoeducation about indoor air related symptoms and personal health behavior factors integrated on patients individual symptomatology, cognitive restructuring, behavioral experiments of patients health promoting behavior, imagery rescripting and relapse prevention.

Intervention: Behavioral: Psychotherapy (CBT)

Experimental: Applied relaxation group therapy

There will be seven (7) manualized session, first 120 minutes and six (6) 90-minute group sessions conducted at weekly intervals, last two sessions 2 weeks intervals. One booster session will be conducted three months after treatment. Sessions include information about indoor air related symptoms, behavioral training and experiments focusing on applied relaxation technique and relapse prevention.

Intervention: Behavioral: group therapy (ART)

NB: The Applied Relaxation group Therapy won´t be carried out due to slow and prolonged recruiting process (A steering group agreement 4/2015 and the Ethics Committee approval 5/2015 for the change of the study plan).

Experimental: Information session (psychoeducation)

There will be one (1) manualized 90-minute individual session. The session includes information about indoor air related symptoms and factors affecting individual health behavior.

Intervention: Information session (psychoeducation)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
15D - instrument
Time Frame: baseline, 3, 6 and 12 months from the baseline
The health-related quality of life (HRQoL) instrument (Sintonen, 2001)
baseline, 3, 6 and 12 months from the baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
• Generalized Anxiety Disorder (GAD-7)
Time Frame: baseline, 3, 6 and 12 months from the baseline
Self-report measure that assesses anxiety symptoms
baseline, 3, 6 and 12 months from the baseline
Insomnia Severity Index (ISI)
Time Frame: baseline, 3, 6 and 12 months from the baseline
Self-report measure that assesses insomnia severity
baseline, 3, 6 and 12 months from the baseline
The Symptom checkList-90 (SCL-90)
Time Frame: baseline, 6 and 12 months from the baseline
Self-report measure that assesses general psychological and somatic symptoms and severity
baseline, 6 and 12 months from the baseline
The Patient Health Questionnaire (PHQ-9)
Time Frame: baseline, 3, 6 and 12 months from the baseline
Self-report measure that assesses depressive symptoms
baseline, 3, 6 and 12 months from the baseline
Visual Analogue Scale (VAS)
Time Frame: baseline, 3, 6 and 12 months from the baseline
Self-report measure that assesses respiratory symptom severity
baseline, 3, 6 and 12 months from the baseline
The Acceptance and Action Questionnaire-2 (AAQ-2)
Time Frame: baseline, 3, 6 and 12 months from the baseline
Self-report measure focuses on experiential avoidance and psychological inflexibility
baseline, 3, 6 and 12 months from the baseline
Illness Worry Scale (IWS)
Time Frame: baseline, 3, 6 and 12 months from the baseline
Self-report measure that focuses on illness worries and attitudes towards illness
baseline, 3, 6 and 12 months from the baseline
Penn State Worry Questionnaire (PSWQ)
Time Frame: baseline, 3, 6 and 12 months from the baseline
Self-report measure that focuses on mourning and continuous worrying toughs
baseline, 3, 6 and 12 months from the baseline
Need for Recovery (NRF)
Time Frame: baseline, 3, 6 and 12 months from the baseline
Self-report measure that focuses on time needed on the recovery after work day
baseline, 3, 6 and 12 months from the baseline
Strategy and Attribution Questionnaire (SAQ)
Time Frame: baseline, 6 and 12 months from the baseline
Self-report measure focuses on personal attribute strategies.
baseline, 6 and 12 months from the baseline
Self-assessed work ability
Time Frame: baseline, 3, 6 and 12 months from the baseline
Self-assessed work ability (on a scale 0-10) (Tuomi & al. 1998)
baseline, 3, 6 and 12 months from the baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Working Alliance Inventory (WAI)
Time Frame: after the first, fifth and the last session of the CBT
Self-report measure that assesses three key aspects of the therapeutic alliance: (a) agreement on the tasks of therapy, (b) agreement on the goals of therapy and (c) development of an affective bond; for therapists and the patient of the individual cognitive-behavior therapy
after the first, fifth and the last session of the CBT
Sense of coherence Group (SOC-G-20)
Time Frame: after the first, fourth and the last session of the grouptherapy
For the group therapy patients to evaluate the groups therapeutic alliance.
after the first, fourth and the last session of the grouptherapy
Satisfaction of the treatment
Time Frame: 3, 6 and 12 months from the baseline
Questionnaire for the intervention groups patients to evaluate the satisfaction of the treatment and its efficacy.
3, 6 and 12 months from the baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2014

Primary Completion (Actual)

July 29, 2018

Study Completion (Actual)

July 30, 2018

Study Registration Dates

First Submitted

February 20, 2014

First Submitted That Met QC Criteria

February 20, 2014

First Posted (Estimate)

February 21, 2014

Study Record Updates

Last Update Posted (Actual)

August 7, 2018

Last Update Submitted That Met QC Criteria

August 6, 2018

Last Verified

February 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • TSR113076
  • TTL338270202 (Other Grant/Funding Number: Finnish Institute of Occupational Health (Finland))

Plan for Individual participant data (IPD)

Study Data/Documents

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Environmental Illness

Clinical Trials on Cognitive-Behavioral Therapy (CBT)

3
Subscribe